Listen to this post

Introduction

The Insurance Regulatory and Development Authority of India (“IRDAI”) has notified the IRDAI (Registration of Indian Insurance Companies) Regulations, 2022 (“2022 Regulations”), on December 8, 2022. The 2022 Regulations consolidate various prescriptions relating to registration of Indian insurance companies and the transfer of shares of such entities. Previously, such prescriptions were dispersed across multiple regulations, circulars, and guidelines such as the IRDAI (Listed Indian Insurance Companies) Guidelines, 2016, and the IRDAI (Investment by PE Funds in Indian Insurance Companies) Guidelines, 2017 (“2017 PE Guidelines”).

With the introduction of the 2017 PE Guidelines, the IRDAI had attempted to make the sector more conducive for PE investments. The IRDAI had provided some much-needed clarity on investment in insurance companies by PE funds. Though the 2017 PE Guidelines had codified some practices that had already been developed and implemented by the IRDAI, it also brought in the new requirement of PE Funds having to invest through a Special Purpose Vehicle (“SPV”) in case of promoter stakes. The requirement of an SPV has been one of the most controversial provisions of the 2017 PE Guidelines. Various stakeholders have, over time, highlighted the tax implications and administrative burdens of the SPV requirement.

The 2022 Regulations now consolidate and address various aspects related to investments in insurance companies. Our analysis of these aspects, particularly from the PE funds’ perspective, indicates that these changes have been made to further ease of doing business in the insurance industry.

Expanding the Definition of PE Fund

The definition of a “PE Fund” under the 2017 Guidelines was an inclusive one, which included alternative investment funds registered with the Securities and Exchange Board of India (SEBI) or a fund specifically formed for investment in one or more entities by one or more persons and included domestic and foreign PE funds. Under the 2022 Regulations, the definition of “PE Fund” has been broadened to include investment funds registered with the International Financial Services Centres Authority (IFSCA), as well as all such funds that are specifically formed for investments, subject to the condition that such fund or their manager is registered with the appropriate financial sector regulator of their originating jurisdiction.[1]

Conditions for a PE Fund investing as a Promoter and omission of the Special Purpose Vehicle (SPV) requirement

To the relief of the industry, the 2022 Regulations removed the mandatory SPV requirement for a PE Fund to invest in an insurer in the capacity of a promoter. This implies that there is no longer any need for a PE Fund to invest in an insurer through an SPV, even if such investment is in the capacity of a promoter. This eliminates the tax and administrative burden on PE Funds, which wish to promote an insurance company. However, in the event the PE Fund (for structuring purposes or otherwise) desires to invest though an SPV, the same is still permitted, subject to compliance with Regulation 6(3) of the 2022 Regulations.

The 2022 Regulations provide a list of entities that can be an “Indian Promoter”[2], which include any other entity permitted by the IRDAI which meet the criteria of a ‘promoter’, as defined under the Companies Act, 2013. A “Foreign Promoter” has also been broadly defined to include any person that meets an illustrative criteria, which also resembles the criteria of a ‘promoter’ as defined under the Companies Act, 2013.[3] In light of this, a PE Fund can either be an “Indian Promoter” or a “Foreign Promoter” as long as it fulfils the conditions of a ‘promoter’[4]. However, for such an investment as a promoter, the PE Fund will need to fulfil the following criteria:

  1. The manager of the PE Fund or its parent fund has completed 10 years of operation;
  2. The funds raised by the PE Fund, including its group entity(ies), is USD 500 million or more (or its equivalent in INR);
  3. The investible funds available with the PE Fund is not less than USD 100 million; and
  4. The manager of the PE Fund has invested in the financial sector in India or other jurisdictions.

Such eligibility criteria derive its foundations from the 2017 PE Guidelines. These foundations, coupled with the regulatory experience, ensure that only serious investors are welcomed to the industry. Do note that in addition to these requirements, the PE Fund will, in any case, require to satisfy the fit and proper criteria set out under Regulation 6(2), read with Schedule I of the 2022 Regulations.[5]

Additionally, the IRDAI has also permitted NOFHC, registered with the Reserve Bank of India, or a company incorporated under the Companies Act, 2013, to be an ‘Indian Promoter’. This implies that a PE Fund has the flexibility to decide the structuring of its investment vis-à-vis whether to invest through an SPV (through the abovementioned entities) or whether to invest directly.

Promoter Holding

Under the 2017 PE Guidelines, an investment of over 10% in the paid up capital of an insurer necessarily had to be made as a ‘promoter”.[6] Under the 2022 Regulations, the promoter threshold has been raised from the erstwhile 10% of the paid up capital of an insurer to 25% of the insurer’s paid up capital and consequently, the investor threshold has increased from “up to 10%” of the insurer’s paid up capital to “up to 24.99%” of the insurer’s paid up capital.[7]

The 2022 Regulations have also overhauled the minimum promoter shareholding criteria. The minimum collective promoter holding was set at 50% of the paid-up share capital of an insurer, which can be further reduced to 26% in case of a listed insurer having a satisfactory solvency record for the preceding five years.[8] There is no requirement for an Indian or Foreign Promoter to hold any minimum shares individually. This paves the way for a diverse shareholding pattern among insurance companies.

Lock-in and other obligations

Given that the maximum permissible investment by an ‘investor’ has been increased to ‘up to 24.99%’, there are additional obligations that have been introduced on investors. The IRDAI has provided for a staggered lock-in requirement under the 2022 Regulations on shares of an insurance company. The primary lock-in applicable on all shareholders is five years from the date of grant of certificate of registration.

All investments made post the date of grant of certificate of registration (for example through a rights issue) do not impact the lock-in on the shares acquired earlier. Gradually, as the insurer ages, the lock-in period has been reduced to two years for a promoter and one year for an investor on their new investment. The lock-in provisions, except for the initial lock-in and investment during the initial lock-in, apply on issue of new shares, which result in change in shareholding pattern.

The lock-in provisions are as follows:

Time of Investment (“X”)  Lock-in Period (Years) FOR PromotersLock-in Period (Years) FOR Investors
Investment at the time of or before grant of Certificate of Registration (“R3”)  5 years from R35 years from R3
Investment within 5 years of R3Earlier of the following: a) 5 years from X; or b) 8 years from R3  Earlier of the following: a) 5 years from X; or b) 8 years from R3
Investment after 5 years from R3 but before 10 years from R3Earlier of the following: a) 3 years from X; or b) 12 years from R3  Earlier of the following: a) 2 years from X; or b) 11 years from R3
Investment After 10 years from R32 years from X    1 year from X

Multiple Investments in Single Class of Insurance Business

By virtue of the 2022 Regulations, the IRDAI has permitted a person to hold stakes in multiple insurers undertaking the same class of insurance business. In this regard, the key points are below:

The 2022 Regulations provide that an investor holding 10.01-24.99% of equity capital can invest in two insurers of each class of insurance business and has the right to nominate director(s) on the Board of such insurers.[9]

FDI in Insurance Companies

The 2022 Regulations also consolidate various prescriptions in relation to Foreign Direct Investment (“FDI”) in insurance companies, particularly the manner of calculation of FDI in an insurance company, requirement of resident Indian citizenship for directors and key managerial personnel as well as requirement for foreign investors exceeding 49% of the insurer. There has been no change in the principles of substantive law and discussion on the same can be found in our blog post dated August 22, 2022 .

Key Changes in 2022 Regulations vis-à-vis the previous legal regime

The Road Ahead

A master circular on the 2022 Regulations has been notified by the IRDAI on April 24, 2023. The said master circular covers the procedural aspects with respect to seeking registration as an insurer and transfer of shares by providing the various  forms that were previously contained in the erstwhile regulations, along with providing certain clarifications on the 2022 Regulations. The IRDAI has duly withdrawn the 2017 PE Guidelines. Our analysis of the said master circular can be found here.

The IRDAI has brought in a slew of reforms, aimed at increasing ease of doing business through advanced supervisory clarity. Many previous practices of the IRDAI have now been codified and will be able to provide a bird’s eye view to an investor wishing to invest in Indian insurance companies. The rationalisation of various regulatory requirements will help bring in a higher flow of investments in the sector, thus equipping insurers with enough capital to achieve the ‘insurance for all’ mission by 2047.


[1] Regulation 2(l) of the 2022 Regulations.

[2] Regulation 2(h) of the 2022 Regulations.

[3] The criteria resembles the definition of ‘promoter’ under section 2(69) of the Companies Act, 2013.

[4] It is pertinent to note that the Exposure Draft of the 2022 Regulations provided that trusts were disqualified to be an ‘Indian Promoter’. Given that PE Funds are often organized as trusts and partnership firms, the IRDAI has accepted industry recommendations to omit such references from the final regulations.

[5] Schedule I contains an indicative criteria including financial strength, ability to access capital, approval by regulatory bodies outside India, convictions against the entity by statutory or judicial bodies in or outside India, agreement between shareholders and impact on control and management, source of funds and beneficial ownership of shares of investors or promoters.

[6] Paragraph 3(2) of 2017 PE Guidelines.

[7] Regulation 6(7) of the 2022 Regulations.

[8] Regulation 6(6) of the 2022 Regulations.

[9] Regulation 6(7)(iii) of the 2022 Regulations. This resolves issue whether an investor having a board seat should mandatorily be classified as a promoter or not.

 

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Indranath Bishnu Indranath Bishnu

Indranath is a partner with Cyril Amarchand Mangaldas and is a part of the general corporate practice in the Mumbai region. His work is focussed on the Insurance industry where he specializes in mergers and acquisitions and joint ventures and regulatory matters. He…

Indranath is a partner with Cyril Amarchand Mangaldas and is a part of the general corporate practice in the Mumbai region. His work is focussed on the Insurance industry where he specializes in mergers and acquisitions and joint ventures and regulatory matters. He is currently  leading the team from Cyril Amarchand Mangaldas engaged to advise the Regulations Reforms Committee constituted by the Insurance Regulatory and Development Authority. He has advised various government bodies including Department of Financial Services (Ministry of Finance) and the Insurance Regulatory and Development Authority of India on reforms in the insurance sector. He currently serves as a member on the committee constituted by the Insurance Regulatory and Development Authority of India to study and recommend capital requirements for Insurance entities. On the transactional side, Indranath advises multiple corporations, both Indian and foreign, in relation to investments in the insurance sector as well as establishment, operation, management and control of insurance companies and intermediaries in India.  He can be reached at indranath.bishnu@cyrilshroff.com

Photo of Anirud Sudarsan R Anirud Sudarsan R

Principal Associate in the General Corporate practice at the Mumbai office of Cyril Amarchand Mangaldas. Anirud joined the firm in the year 2017 after graduating from West Bengal National University of Juridical Sciences, Kolkata. He advises clients, which include promoters and investors of…

Principal Associate in the General Corporate practice at the Mumbai office of Cyril Amarchand Mangaldas. Anirud joined the firm in the year 2017 after graduating from West Bengal National University of Juridical Sciences, Kolkata. He advises clients, which include promoters and investors of insurers, private equity funds, insurance companies and insurance intermediaries, on mergers & acquisitions and foreign investments in India.

He has worked on several transactions in relation to acquisition of private and public companies, business transfers and initial public offerings in the Indian insurance sector. Anirud also regularly advises insurers and insurance intermediaries in relation to, amongst other aspects: Corporate Governance, General Corporate Strategies, Business Ventures and Partnerships, Distribution and other forms of engagement between insurers and insurance intermediaries and Data Protection, Data transfer, Data Localisation. He can be reached at anirud.sudarsan@cyrilshroff.com

Photo of Shravan Belsare Shravan Belsare

Associate in General Corporate practice in the Mumbai office of Cyril Amarchand Mangaldas. He joined the firm in the year 2021 after graduating from Gujarat National Law University, Gandhinagar. He regularly advises in matters relating mergers & acquisitions and private equity investments with…

Associate in General Corporate practice in the Mumbai office of Cyril Amarchand Mangaldas. He joined the firm in the year 2021 after graduating from Gujarat National Law University, Gandhinagar. He regularly advises in matters relating mergers & acquisitions and private equity investments with focus on insurance sector and the international financial services centres. He advises on mergers & acquisitions, private equity, insolvency, and foreign investments in India. He advises both Indian and foreign companies, in relation to investments in the insurance sector as well as establishment, operation, management and control of insurance companies in India. He can be reached at shravan.belsare@cyrilshroff.com